The Epithelial
Site Search
A group of care centers that have expertise in nontuberculous mycobacteria research and treatment have formed a consortium to conduct studies that seek to standardize the diagnosis and treatment of the bacterial infections.
The Therapeutics Development Network Coordinating Center Biostatistics and Clinical Data Management team has extensive expertise in the support of both controlled clinical trials and observational studies. We offer full statistical and data management support -- from planning to implementation to reporting.
The Therapeutics Development Network Coordinating Center can provide coverage and coordination for the review and reporting of serious adverse events that may occur during the course of cystic fibrosis clinical studies.
The Therapeutics Development Network's (TDN) Protocol Review Process ensures optimum safety and quality in cystic fibrosis clinical trial protocols.
These award opportunities are designed to support clinical fellows pursuing training in cystic fibrosis-relevant subspecialties.
The Clinical Research Executive Committee (CREC) assesses how a specific protocol fits within the overall clinical research priorities of the cystic fibrosis community and assigns it a rating.
This award provides the opportunity for clinically trained physicians to develop into independent biomedical research investigators who are actively involved in cystic fibrosis-related areas.
The intent of the planning grant is to support the planning of a large, multi-center, investigator-initiated clinical research study that addresses a therapy initiation and modification on ETI (TIME) area of interest.
This award will provide up to six years of support for outstanding, newly trained pediatricians and internists (MDs and MD/PhDs) to complete sub-specialty training, develop into independent investigators, and initiate a research program.